🇺🇸 FDA
Patent

US 11447573

Multispecific antigen binding proteins and methods of use thereof

granted A61KA61K2039/505A61P

Quick answer

US patent 11447573 (Multispecific antigen binding proteins and methods of use thereof) held by Nanjing Legend Biotech Co., Ltd expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nanjing Legend Biotech Co., Ltd
Grant date
Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61P, A61P29/00, A61P35/00